Is vaxigrip trivalent or quadrivalent?

VaxigripTetra™ (IIV4; Sanofi Pasteur) is a quadrivalent split-virion influenza vaccine approved in Europe in 2016 for individuals ≥ 3 years of age. IIV4 builds on the well-established record of the trivalent split-virion influenza vaccine (Vaxigrip®).

What is Vaxigrip vaccine?

Vaxigrip Tetra is a vaccine. This vaccine helps to protect you or your child against influenza (flu). Vaxigrip Tetra is used to prevent flu in persons of 6 months of age and older. If you are pregnant, one dose of vaccine given to you during pregnancy may protect your baby from birth to less than 6 months of age.

What does a trivalent influenza vaccine consist of?

A synthetic vaccine consisting of three inactivated influenza viruses, two different influenza type A strains and one influenza type B strain. Trivalent influenza vaccine is formulated annually, based on influenza strains projected to be prevalent in the upcoming flu season.

What is the trivalent flu vaccine?

The trivalent vaccine protects against three strains of the flu; these include two strains of influenza A and one of influenza B. The B strain included is based on the strain that researchers expect to be the most widespread each year.

Is vaxigrip funded?

Fluarix® Tetra/FluQuadri®/Afluria® Quad/Vaxigrip Tetra®/Influvac® Tetra/ Flucelvax® Quad are licensed for those ≥ 65 years of age but are not the preferred vaccine of choice. Purple shaded boxes indicate the vaccine is funded under the NIP for eligible people.

What is adjuvanted trivalent influenza vaccine?

The adjuvanted influenza vaccine is a trivalent vaccine, meaning it is designed to protect against three different influenza viruses, two influenza A viruses and one influenza B virus. In Ontario Fluad® is publicly funded for residents of long-term care homes (LTCHs) aged 65 years and older.

Does the same brand of influenza vaccine need to be used?

Influenza vaccine brands are interchangeable. Always ensure that the age-appropriate brands are administered.